Citius Oncology
Price & Volume
Stats
See more52W Range | $0.49-$2.25 |
Market Cap | $88.8M |
Shares Short | 289,717 |
Financials
See moreRevenue (12 Mos) | $7.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $5.3M |
Diluted EPS | -$0.48 |
News
See moreYahoo Finance • 2 months ago
Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum
Yahoo Finance • 5 months ago
Citius raises $36.5m for Lymphir commercialisation
Yahoo Finance • 10 months ago
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
Yahoo Finance • 10 months ago
Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment
About
CEO | Mr. Leonard L. Mazur |
CFO | Mr. Jaime Bartushak |
Address | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |